Krystal Biotech, Inc. Common Stock KRYS
$337.02
-1.84%
at last close
Financials (TTM)
- Revenue
- $440.48 million
- Net Income
- $241.47 million
- Net Margin
- 54.82%
- Return on Equity
- 17.77%
- Debt-to-Equity
- —
- P/E Ratio
- 42.23
- Price / Book
- 7.48
- Price / Sales
- 23.07
Over the trailing twelve months, Krystal Biotech, Inc. Common Stock generated revenue of $440.48 million and net income of $241.47 million, a net margin of 54.82%.
At the last closing price of $337.02, KRYS trades at 42.23 times trailing earnings and 23.07 times sales, with a market capitalization of $10.16 billion.
Key Stats
- Last Close
- $337.02
- Market Cap
- $10.16 billion
- 52-Week Range
- $130.50 – $382.54
- Average Volume
- 496K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.